key: cord-0809109-6zie2yfn authors: Tiwari, N.; Nath, D.; Madan, J.; Singh, S.; Bajpai, P.; Madan, U. title: The Neutrophil Lymphocyte Ratio (NLR), Platelet Lymphocyte Ratio (PLR) and routine hematological parameters of COVID-19 Patient : A perspective of the Indian scenario from a frontline pilot study of 32 COVID-19 cases in a Tertiary Care Institute of North India date: 2020-06-01 journal: nan DOI: 10.1101/2020.05.29.20102913 sha: 9d8da4a82734e0257383c81b5b3b08c8ae4b0b82 doc_id: 809109 cord_uid: 6zie2yfn Introduction The coronavirus disease 2019(COVID-19) is caused by the virus SARS-CoV-2 and is declared as a global pandemic by the World Health Organization (WHO). Various hematological parameters alteration has been documented in the Chinese literature in SARS-Cov-2 infection. However, there is a need for research to evaluate the pattern of the hematological parameters of COVID-19 patients in the Indian population. Aims & Objectives: The objective of the study is to see the Neutrophil-Lymphocyte Ratio (NLR), Platelet Lymphocyte Ratio (PLR), and other hematological parameters alteration of COVID-19 patients along with their clinical course in the Indian scenario. Methods: A single-center prospective study of 32 patients with laboratory-confirmed COVID-19 admitted to Super Speciality Pediatric Hospital & Post Graduate Teaching Institute NOIDA, from March to April, were enrolled for the study. The demographic data, the clinical status of the patients during admission and follow up, baseline, and follow up hematological findings were recorded. Statistical analysis of the data was carried out, and relevant findings were presented. Results: Demographic characterization shows a mean age of 37.7 years, male (41.9%), female (58.1%)with the majority of patients are mildly symptomatic to asymptomatic(93%). The CBC values and NLR, PLR at baseline between the male and the female patients, are not showing any statistically significant difference as the 95% C.I. A statistically significant increment in the lab parameters is observed in follow-up visits. Conclusion: The majority of the patients are younger and have mild clinical presentation with female predominance. Pediatric cases have mild symptomology. Baseline CBC findings show mild neutrophilia, lymphopenia, eosinopenia, and normal to mild thrombocytopenia. An increase in CBC parameters, NLR was noted in follow up cases. Anemia was not noted in baseline CBC and in the follow-up group. A onetime PLR is not indicative of disease progression. Key words: Corona virus,COVID-19,CBC,NLR,PLR E-Mail: d e v a j i t _ n a t h @ y a h o o . The primary objective of the study is to see the Neutrophil-Lymphocyte Ratio, Platelet Lymphocyte Ratio, and other hematological parameters alteration of COVID 19 Patients in the Indian scenario. The secondary objective of the study is to assess the follow up hematological parameters of the patients in order to obtain key indicators of disease progression and outcome that will provide guidance for subsequent clinical practice. The demographic date, the clinical status of the patients during admission, and follow up and hematological findings were recorded. The samples for complete blood count (CBC) and peripheral smears for microscopy examination were collected on the day of admission. All patients didn't receive any treatment before blood sampling. The samples were tested for complete . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2020. . https://doi.org/10.1101/2020.05.29.20102913 doi: medRxiv preprint blood count on 5-part hematology analyzer Abbott Cell Dyn Ruby, and values were noted. Peripheral blood smears were stained by Romanowsky stains, and findings were noted. The patients whose clinical status remained unchanged were reexamined for laboratory indexes. The composite endpoint of the study was a clinical improvement, stability, or deterioration. Dates are presented on means and standard deviation (SD) . Differences in values between tested confidence intervals were calculated. Correlation analysis used a simple linear correlation. The optimal cutoff. Value, sensitivity, and specificity of NLR, PLR, and other CBC variables were determined, paired T-test was applied, and follow up data presented separately. All statistical analyses were carried out by SPSS 15.0 (SPSS Inc., Chicago, USA). A total of 32 patients were admitted with a mean age of 37.7 years (4 months to 81 years), including males & Females. There were 29 cases in the mild group and 3 cases in the moderate/severe group. Patients in the moderate group were older than the cases in the mild category, with a case of an 81-year-old patient being recorded as the oldest in our institute. Females constitute 58.10%, and males constitute 41.9% of the study population. The median follow up time was of 2 weeks. All the paediatric cases under study were stable and asymptomatic, with only supportive treatment. Adult patients included in the study were given supportive treatment, and only one case showed clinical deterioration over a period of 14 days of admission. The statistical analyses of the data are being summarized in the table and graphs. The lab values at baseline are not showing any statistically significant difference as the 95% Confidence Interval (C.I). There is no statistically significant difference in the lab parameters . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2020. . https://doi.org/10.1101/2020.05.29.20102913 doi: medRxiv preprint between males and females at the baseline visit. The baseline Lab values of Follow-up cases are also not showing any statistically significant difference as the 95% Confidence Interval (C.I) for the mean of lab parameters are falling within the acceptable lab ranges (Normal ranges as per 5 part Hematology Analyzer Reference Value within the parentheses) Table 3 : Statistical analysis of the follow-up CBC data available for 3 cases in the symptomatic (moderate to severe symptoms) group. A statistically significant increment in the lab parameters is observed in follow-up visit 2 & visit 3, but a larger follow-up data needs to be studied for better delineation of the results (N=3 In our analysis, 6 cases were seen with baseline NLR above the standard risk stratification cut off value of 3.13. This was not statistically significant. However, out of the 6 cases, 3 cases were symptomatic with high NLR both in baseline CBC and on follow up after 14 days, which was statistically significant. From the above statistical analysis, it can be presumed that the longer the virus remains in the human body, the CBC parameters are affected, but in the earlier phase of onset of disease or symptoms, significant alteration of the CBC parameters are not observed. coronavirus, SARS-CoV-2, that was first recognized in Wuhan, China, in December 2019. Genetic sequencing of the virus suggests that SARS-CoV-2 is a beta-coronavirus closely linked to . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2020. Since asymptomatic persons are not routinely tested, the prevalence of asymptomatic infection and detection of pre-symptomatic infection is not well understood. Clinical and epidemiological data of the asymptomatic and mildly symptomatic cases in Indian lacks to provide an illustration of the epidemiological curve of disease outbreak in the Indian population. Data from our study shows that most of the patients are asymptomatic to mildly symptomatic (90.3%), thus correlating with other studies in the Chinese and the Western population. The demographic characteristics of our study showed that females were affected more often than men. This is in contrast to various studies conducted by Guan WJ et al 8 , Zhang JJ et al 9 , Nanshan Chen et al 10 , where the disease incidence was more in men as compared to females. Previous studies conducted on SERS COV and MERS have also been found to infect more males than females 11, 12 . The reduced susceptibility of females to viral infections could be attributed to the protection from X chromosome and sex hormones, which play an important role in innate and adaptive immunity 13 . The change in the gender pattern in the Indian population could be due to immunological, ethnic, or racial variation. This area needs further research, and a larger cohort study may be suggested to establish the fact. A study conducted by Li et al. on the first 425 cases of COVID 19 in Wuhan; China showed that the patients' median age was 59 years, with a range of 15 to 89 years 14 . However, in our study, the median age was 37.7 years (4 months-81 years). In our study group, pediatric cases comprise 12.9% of the total cases. This is in contrast to the study conducted by Li is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2020. . https://doi.org/10.1101/2020.05.29.20102913 doi: medRxiv preprint progression toward severe or critical forms of COVID-19, include leukocytosis, neutrophilia, and lymphopenia. Each of these prognostic parameters retains a specific clinical and biological significance, which, altogether, can contribute to reflect the evolution toward more unfavorable clinical pictures. Huang C et al. and Yang X mentioned in their articles whereby 85% of the critically ill patients of their study group with COVID-19 showed lymphopenia 16, 17 . The presence of lymphopenia as a signature of severe COVID-19 was confirmed by Bai et al., who reported that ICU patients suffering this infection had a median lymphocyte count of 800 cells/mm 18 with -non-survivors exhibiting persistent lymphopenia. As per the IFCC guidelines, the CBC parameters in a COVID case show neutrophilia, leucocytosis lymphopenia, and thrombocytopenia (IFCC Information Guide on COVID-19; published Thursday, March 26: https://www.ifcc.org/ifcc-news/2020-03-26-ifcc-informationguide-on-covid-19/).In another Chinese study, which has analyzed data from two laboratory parameters, "normal/ decreased number of leukocytes" or "decreased number of lymphocytes," as Analysis of the baseline CBC parameters of our study population showed that 4 cases (12.9%) showed neutrophilia, 3(9.6%) cases showed lymphopenia (ALC < 1 × 10 9 /L), and 5 cases (16.1%) showed monocytosis. However, the baseline total leucocyte count was not increased. The lower percentage of cases showing lymphopenia in our study is in contrast to the other studies conducted in China, whereby 63% of cases showed lymphopenia and 42% cases outside the Chinese population 15, 19 . The disparity in the percentage of cases showing lymphopenia may, in part, be reflective of the epidemiological variation of the Indian population. The finding of monocytosis in our study has not been documented in other studies. Out of the 32 cases, 8 cases (25.8%) had eosinopenia. Our findings matched with a single Chinese study, which also highlights eosinopenia as a significant prognosticating factor 20 . The study proposes Eosinopenia as a potentially more reliable laboratory predictor of SARS-CoV-2 infection than recommended "leukocyte counts" and "lymphopenia" 20 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2020. In our analysis, 6 cases were seen with baseline NLR above the cut off 3.13. This was not statistically significant. However, out of the 6 cases, 3 cases were symptomatic with high NLR both in baseline CBC and on follow up after 14 days, which was statistically significant. From the study, it could be concluded that baseline CBC parameters of all the 32 cases presenting with mild to moderate symptoms did not show any statistically significant variation in the parameters that may substantially mark their clinical progress or severity. Also, there is no . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2020. . https://doi.org/10.1101/2020.05.29.20102913 doi: medRxiv preprint statistically significant difference in the lab parameters between males and females at the baseline visit. One reason for this observation could be due to the limited sample size or early /asymptomatic/mild presentation of COVID cases. In the follow-up group, the lab values at Follow-up visit one are not showing any statistically significant difference in the CBC parameters. A statistically significant increment in the lab parameters like TLC, neutrophils, monocytes was seen while increasing lymphopenia, and developing eosinopenia was also seen in is follow-up visit 2 & visit 3. Platelet count and hemoglobin levels remained unchanged even with disease progression in our study. The statistically significant increment in the CBC parameters in this follow up group was correlating with the patient clinical status. A small follow up group is a statistical limitation of our study. A follow-up analysis of CBC Parameters of a large Indian cohort is suggested to statistically prove the association of parameters with prognosis. In a recently discussed paper, it is suggested that in addition to various mechanisms, SARS-CoV-2 viral protein infects hemoglobin by the immune hemolysis of red blood cells 28 . However, in our study, the baseline RBC count and hemoglobin levels were not changed in all the 32 cases and in the 3 follow up cases on 1 st , 2 nd , 3 rd reading. These statistically insignificant findings of baseline CBC in Indian population with a stable clinical course as compared to other foreign data are promising and could explain worse COVID-19 outcome in western countries, unlike India which is leading globally in disease containment with only 12759 cased,1515 recoveries and only 420 deaths compared to world data of 1,40,773 deaths (0.29% of the world deaths). However, a relevant trend in follows up CBC in a large Indian cohort might predict the disease progression and prognosis. There may be missing laboratory data as CBC investigation was not performed daily on all patients, especially those who are minimally symptomatic and improving in the general Isolation Ward. Also, a very low sample size of follow up as well as no follow up cases analyzed is a big limitation for definitive statistical findings. The study of 32 COVID-19 cases of Indian population shows that majority of the patients are younger, have asymptomatic to mild clinical presentation, and a higher incidence in the female population. The majority of pediatric cases have mild symptomology with a stable clinical course. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2020. . https://doi.org/10.1101/2020.05.29.20102913 doi: medRxiv preprint -Baseline CBC findings of all the cases show mild neutrophilia, mild lymphopenia, eosinopenia, mild monocytosis, and a normal to mild thrombocytopenia. However, the statistical distributions of the parameters were within the normal range without any association of disease progression. Peripheral blood smear examination in our cases showed a predominantly normocytic normochromic picture with few cases showing toxic granules in neutrophils while the occasional case showed activated lymphoid cells. -A significant statistical trend of increase in CBC parameters, NLR, was noted in follow up cases with persistent symptoms; however, a larger follow-up cohort is needed to arrive at a statistical significance. -Anemia was not noted in baseline CBC and in the follow-up group. -A onetime PLR is not indicative of disease progression. The study obtained data from 32 COVID-19 cases in NOIDA, India to explore the epidemiology and the baseline and follow up hematological parameters of the patients. The pilot study provides further information on the demographic and laboratory hematological parameters of the patients thereby adding substantial inputs to the knowledge data base. The present study shows that in India majority of the cases have asymptomatic to mild clinical presentation with female outnumbered the male and a majority of pediatric cases have mild symptomology with stable clinical course. No statistically significant baseline hematology parameters alteration was noted in the study group however follow up cases show statistical significance in the parameters. The slightly different epidemiological and hematological pattern of the Indian cases will help the clinicians and the researchers for better understanding of the disease pattern with timely management of the epidemic. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2020. . https://doi.org/10.1101/2020.05.29.20102913 doi: medRxiv preprint Current literature review documents the epidemiological and hematological parameter alteration of the COVID-19 patients in the Chinese and the western population, thereby perpetuating a knowledge deficit in the Indian population where the pandemic is spreading over time. The study obtained data from 32 COVID-19 cases in NOIDA, India to explore the epidemiology and the baseline and follow up hematological parameters of the patients. The pilot study provides further information on the demographic and laboratory hematological parameters of the patients thereby adding substantial inputs to the knowledge data base. The present study shows that in India majority of the cases have asymptomatic to mild clinical presentation with female outnumbered the male and a majority of pediatric cases have mild symptomology with stable clinical course. No statistically significant baseline hematology parameters alteration was noted in the study group however follow up cases show statistical significance in the parameters. The slightly different epidemiological and hematological pattern of the Indian cases will help the clinicians and the researchers for better understanding of the disease pattern with timely management of the epidemic. Dr Devajit Nath . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2020. . https://doi.org/10.1101/2020.05.29.20102913 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2020. . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2020. . https://doi.org/10.1101/2020.05.29.20102913 doi: medRxiv preprint Clinical management of severe acute respiratory infection in returning travelers from Wuhan, China Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Clinical characteristics of coronavirus disease 2019 in China Clinical characteristics of 140 patients infected with SARS CoV 2 in Wuhan Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis Clinical features of patients infected with 2019 novel coronavirus in Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Presumed asymptomatic carrier transmission of COVID-19 Dysregulation of immune response in patients with COVID-19 in Wuhan Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series A simple laboratory parameter facilitates early identification of COVID-19 patients Platelet to lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease 19 What is the normal value of the neutrophil-to-lymphocyte ratio? Neutrophil-to-lymphocyte ratio predicts severe illness patients with